News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Exelixis, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
March 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and year ended December 31, 2008.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Exelixis, Inc.
MORE ON THIS TOPIC
Obesity
Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows
November 10, 2025
·
3 min read
·
Dan Samorodnitsky
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
November 10, 2025
·
1 min read
·
Annalee Armstrong
Metabolic disorders
Lilly Makes $1.2B RNAi Pact With SangeneBio, Targets Metabolic Diseases
November 10, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pfizer’s Winning Bid for Metsera Concludes ‘Real Housewives of Biopharma’
November 10, 2025
·
3 min read
·
Annalee Armstrong
